Compare OABI & FOSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OABI | FOSL |
|---|---|---|
| Founded | 2012 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Consumer Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 294.3M | 339.5M |
| IPO Year | 2021 | 1994 |
| Metric | OABI | FOSL |
|---|---|---|
| Price | $4.02 | $4.87 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $4.50 | ★ $7.00 |
| AVG Volume (30 Days) | ★ 2.1M | 759.7K |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 6.56 | ★ 25.26 |
| EPS | ★ N/A | N/A |
| Revenue | $18,666,000.00 | ★ $1,004,406,000.00 |
| Revenue This Year | $52.42 | N/A |
| Revenue Next Year | $64.69 | $1.66 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.32 | $1.70 |
| 52 Week High | $5.43 | $6.25 |
| Indicator | OABI | FOSL |
|---|---|---|
| Relative Strength Index (RSI) | 52.30 | 43.25 |
| Support Level | $1.71 | $3.83 |
| Resistance Level | N/A | $5.01 |
| Average True Range (ATR) | 0.35 | 0.24 |
| MACD | -0.11 | -0.09 |
| Stochastic Oscillator | 2.74 | 11.90 |
OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.
Fossil Group Inc is a design, innovation, and distribution company in consumer fashion accessories, offering products such as watches, jewelry, handbags, small leather goods, belts, and sunglasses. It designs, develops, markets, and distributes products under its owned brands FOSSIL, SKAGEN, MICHELE, RELIC, and ZODIAC. It operates through Americas, Europe, and Asia segments, each including sales to wholesale and distributor customers, as well as Company-owned retail stores and e-commerce activities based on the location of the selling entity. The Americas segment contributes the majority of revenue and includes sales across Canada, Latin America, and the United States, while the Europe and Asia segments cover their respective regions. Each segment provides similar products and services.